![]() |
|
|
Vol. 29, Issue 2, 166-171, February 2001
-Methylstyrene in
Rats
Center for Bioorganic Chemistry, Research Triangle Institute,
Triangle Park, North Carolina
-Methylstyrene (AMS) is a volatile hydrocarbon used primarily in
the production of specialty polymers and resins. In the present study,
the tissue distribution, metabolism, and excretion of
[14C]AMS was investigated in male rats after i.v.
administration (11 mg/kg). Over 90% of AMS administered intravenously
to rats was excreted in 72 h. Urinary excretion accounted for 86%
of the administered dose, volatile breath and feces accounted for 2.2 and 1.9%, respectively, and elimination as carbon dioxide was negligible. Metabolites were isolated from rat urine following a high
oral dose of AMS (1000 mg/kg) and characterized using gas chromatography/mass spectrometry and NMR spectrometry. The
metabolites were 2-phenyl-1,2-propanediol (3% of urinary
radioactivity) and its glucuronide (50%), atrolactic acid (27%),
S-(2-hydroxy-2-phenylpropyl)-N-acetylcysteine (13%), and 2-phenylpropionic acid (1%); the glucuronides and
mercapturates were each conjugated on the methylene carbon beta to the
ring. The presence of both of the diastereomeric isomers of the
mercapturates and of the glucuronides suggested that the initial
epoxidation of AMS was not stereoselective and proceeded with addition
of active oxygen to yield enantiomeric epoxides. Incubation of AMS with
human liver slices produced the same metabolites as those excreted in
rat urine, with 2-phenyl-1,2-propanediol present as the predominant
metabolite after 5 h of incubation.
This article has been cited by other articles:
![]() |
L.-J. Chen, E. H. Lebetkin, and L. T. Burka Metabolism of (R)-(+)-Pulegone in F344 Rats Drug Metab. Dispos., December 1, 2001; 29(12): 1567 - 1577. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Obach Cytochrome P450-Catalyzed Metabolism of Ezlopitant Alkene (CJ-12,458), a Pharmacologically Active Metabolite of Ezlopitant: Enzyme Kinetics and Mechanism Of an Alkene Hydration Reaction Drug Metab. Dispos., July 1, 2001; 29(7): 1057 - 1067. [Abstract] [Full Text] [PDF] |
||||